MDSCs-derived GPR84 induces CD8 + T-cell senescence via p53 activation to suppress the antitumor response
Journal for ImmunoTherapy of Cancer · 2023-11 · 11 (11) · e007802
DOI: 10.1136/jitc-2023-007802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 28.11.2023. Verfasst von Jinyan Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: innovation team project within the First Affiliated Hospital of Zhengzhou University, the Major Public Welfare Projects in Henan Province, Henan Provincial Central Leading Local Science and Technology Development Fund Project.
Abstract (Originalsprache)
Backgrounds G-protein-coupled receptor 84 (GPR84) marks a subset of myeloid-derived suppressor cells (MDSCs) with stronger immunosuppression in the tumor microenvironment. Yet, how GPR84 endowed the stronger inhibition of MDSCs to CD8 + T cells function is not well established. In this study, we aimed to identify the underlying mechanism behind the immunosuppression of CD8 + T cells by GPR84 + MDSCs.
Methods
The role and underlying mechanism that MDSCs or exosomes (Exo) regulates the function of CD8 + T cells were investigated using immunofluorescence, fluorescence activating cell sorter (FACS), quantitative real-time PCR, western blot, ELISA, Confocal, RNA-sequencing (RNA-seq), etc. In vivo efficacy and mechanistic studies were conducted with wild type, GPR84 and p53 knockout C57/BL6 mice.
Results
Here, we showed that the transfer of GPR84 from MDSCs to CD8 + T cells via the Exo attenuated the antitumor response. This inhibitory effect was also observed in GPR84-overexpressed CD8 + T cells, whereas depleting GPR84 elevated CD8 + T cells proliferation and function in vitro and in vivo. RNA-seq analysis of CD8 + T cells demonstrated the activation of the p53 signaling pathway in CD8 + T cells treated with GPR84 + MDSCs culture medium. While knockout p53 did not induce senescence in CD8 + T cells treated with GPR84 + MDSCs. The per cent of GPR84 + CD8 + T cells work as a negative indicator for patients’ prognosis and response to chemotherapy.
Conclusions
These data demonstrated that the transfer of GPR84 from MDSCs to CD8 + T cells induces T-cell senescence via the p53 signaling pathway, which could explain the strong immunosuppression of GPR84 endowed to MDSCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.
- Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China yizhang@zzu.edu.cn.
- State Key Laboratory of Esophageal Cancer Prevention & and Treatment, Zhengzhou, Henan, China.
Förderung
- innovation team project within the First Affiliated Hospital of Zhengzhou University
- the Major Public Welfare Projects in Henan Province
- Henan Provincial Central Leading Local Science and Technology Development Fund Project
- National Natural Science Foundation of China
- the National Key Research and Development Program of China
- Healthy Talents Project of Henan Province
- Henan Province Medical Science and Technology Research Provincial and Ministry Co-constructed Projects
- Henan Province Science and Technology Research
Zitieren
APA
Liu, J., Liu, J., Qin, G., Li, J., Fu, Z., Li, J., Li, M., Guo, C., Zhao, M., Zhang, Z., Li, F., Zhao, X., Wang, L., & Zhang, Y. (2023). MDSCs-derived GPR84 induces CD8 + T-cell senescence via p53 activation to suppress the antitumor response. Journal for ImmunoTherapy of Cancer, 11(11), e007802. https://doi.org/10.1136/jitc-2023-007802
Vancouver
Liu J, Liu J, Qin G, Li J, Fu Z, Li J, et al. MDSCs-derived GPR84 induces CD8 + T-cell senescence via p53 activation to suppress the antitumor response. Journal for ImmunoTherapy of Cancer. 2023;11(11):e007802. doi:10.1136/jitc-2023-007802
BibTeX
@article{Liu2023,
author = {Liu, Jinyan and Liu, Jiayin and Qin, Guohui and Li, Jiahui and Fu, Ziyi and Li, Jieyao and Li, Miaomiao and Guo, Caijuan and Zhao, Ming and Zhang, Zhen and Li, Feng and Zhao, Xuan and Wang, Liping and Zhang, Yi},
title = {MDSCs-derived GPR84 induces CD8 + T-cell senescence via p53 activation to suppress the antitumor response},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2023},
volume = {11},
number = {11},
pages = {e007802},
doi = {10.1136/jitc-2023-007802}
}
EUVIMED